Search for: "COBALT PHARMACEUTICALS"
Results 21 - 40
of 70
Sort by Relevance
|
Sort by Date
29 Apr 2014, 1:39 pm
The Supreme Court today granted certiorari in Teva Pharmaceuticals USA, Inc. v. [read post]
28 Mar 2014, 5:33 pm
Procedural History"Defendants-Appellants Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries, Ltd.; Lupin, Ltd.; Lupin Pharmaceuticals, Inc.; Actavis, Inc.; Actavis Elizabeth, LLC; Cobalt Laboratories, Inc.; Cobalt Pharmaceuticals, Inc.; Sun Pharma Global, Inc; Sun Pharmaceutical Industries, Ltd.; Sun Pharmaceutical Industries, Inc.; Wockhardt Ltd.; and Mylan Pharmaceuticals, Inc. [read post]
2 Jan 2014, 6:59 am
It was found in 2010 that cobalt and chromium ions were frequently found in the blood and urine of hip implant patients. [read post]
16 Nov 2013, 3:15 pm
However it is a drop in the bucket for the pharmaceutical giant, which last quarter generated almost $18 billion in revenue and over $3 billion in net income. [read post]
31 Aug 2012, 8:20 am
According to the journal Orthopedics, metal-on-metal hip replacement joints have been found to “exhibit increased serum cobalt and chromium ion levels. [read post]
28 Jun 2012, 10:44 pm
DePuy Orthopedics is the division of Johnson & Johnson, the American pharmaceutical and cosmetic conglomerate, responsible for manufacturing the defective implants. [read post]
15 Mar 2012, 3:10 pm
" However, he explains, some patients have adverse reactions to the metal wear debris caused when the implant ball rubs against the cub and small particles of chromium and cobalt are shed. [read post]
5 Mar 2012, 1:27 pm
And as the Times article points out, with his pharmaceutical sales background he was promoted over another candidate with a background in science and research. [read post]
24 Nov 2011, 4:46 pm
Furthermore, DePuy, a subsidiary of Johnson and Johnson, one of the world's largest medical device and pharmaceutical company, has been eerily quiet. [read post]
20 Nov 2011, 7:01 am
Her expertise is working with employers to reduce workers compensation costs, and her clients include airlines, healthcare, printing/publishing, pharmaceuticals, retail, hospitality, and manufacturing. [read post]
19 Aug 2011, 10:26 am
Exterior enamel finishes come in red, cobalt blue, sand, green, blue, white, mustard, brown and teal. [read post]
14 Jun 2011, 2:14 pm
Stein Mitchell & Muse has filed one of the first local cases involving injuries due to artificial hip implants manufactured by DePuy Orthopaedics, a division of pharmaceutical giant Johnson & Johnson. [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
23 Dec 2010, 9:39 pm
District Court for the District of New Jersey rejected Cobalt Pharmaceuticals' attempt to invalidate Roche's patent covering Boniva for incorrect inventorship. [read post]
17 Nov 2010, 1:48 am
General Where in the world is pharmaceutical innovation? [read post]
11 Nov 2010, 9:59 pm
By James DeGiulio -- Roche Succeeds in Blocking Release of Cobalt's Generic Boniva Hoffman-La Roche successfully secured a preliminary injunction against Cobalt Pharmaceuticals in the patent suit over the bone-loss drug Boniva, thus preventing Cobalt from launching a generic version of the drug. [read post]
27 Oct 2010, 3:38 am
Abbott (EPLAW) Lunesta (Eszopiclone) – US: Cobalt Pharmaceuticals and Sepracor settle Lunesta patent litigation (Patent Docs) Mirapex (Pramipexole) – US: Mylan receives approval for generic version of Mirapex tablets (SmartBrief) Oracea (Doxycyline) – US: Mylan seeks declaratory judgment of non-infringement and invalidity based on ANDA filing: Mylan v Galderma (Patent Docs) Perlane, Restylane (Hyaluronic acid) – US: Genzyme files patent infringement… [read post]
12 Oct 2010, 8:56 pm
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
5 May 2010, 4:46 am
Cyclacel Pharmaceuticals Inc. [read post]
8 May 2009, 8:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Mircera (Methoxy polyethylene glycol-epoetin beta) – US: Federal Circuit revises Amgen v ITC (Patently-O) (Patent Baristas) (ITC 337 Law Blog) (Hal Wegner) (Patent Docs) General Alicia Greenidge to step down as Director of IFPMA (Intellectual Property Watch) Flu crisis could lead to compulsory licences (Managing… [read post]
